In this interview we discuss a study that examined the risk of acute myeloid leukemia in thyroid cancer patients who have been treated with surgery and radioiodine therapy vs those treated with surgery alone.
Sudipto Mukherjee, MD, MPH
Advertisement
Articles by Sudipto Mukherjee, MD, MPH
This video highlights results of a study that examined predictors for unplanned hospital readmissions in patients with hematologic malignancies.
Advertisement
Latest Updated Articles
Risk of AML in Thyroid Cancer Patients Treated With Radioactive IodinePublished: December 21st 2017 | Updated:
Predicting Unplanned Hospital Readmissions in Patients With Hematologic MalignanciesPublished: December 18th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
2
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
3
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
